Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Oligomenorrhea D009839 1 associated lipids
Erythromelalgia D004916 1 associated lipids
Intracranial Hemorrhage, Hypertensive D020299 1 associated lipids
Cholecystitis, Acute D041881 1 associated lipids
Bluetongue D001819 1 associated lipids
Atrial Premature Complexes D018880 1 associated lipids
Heart Septal Defects D006343 2 associated lipids
Retinal Vein Occlusion D012170 2 associated lipids
Weil Disease D014895 2 associated lipids
Pulmonary Heart Disease D011660 2 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Huijgens PC et al. Aspirin does not inhibit human megakaryocyte thromboxane synthesis in vivo. 1986 Scand J Haematol pmid:3081996
Simpson PJ et al. Reduction in the incidence of thrombosis by the thromboxane synthetase inhibitor CGS 13080 in a canine model of coronary artery injury. 1986 J. Pharmacol. Exp. Ther. pmid:3735129
Bucchi F et al. Salicylate may prevent the inhibitory effect of indomethacin on serum thromboxane formation in man. 1986 Prostaglandins Leukot Med pmid:3456617
Zucker ML et al. Platelet function in hypercholesterolemics before and after hypolipidemic drug therapy. 1986 Haemostasis pmid:2939008
Kirschenbaum MA and Chaudhari A Effect of experimental diabetes on glomerular filtration rate and glomerular prostanoid production in the rat. 1986 Miner Electrolyte Metab pmid:3807832
Shohami E and Feuerstein G T-2 toxemia and brain prostaglandins. 1986 Prostaglandins pmid:3457405
Greer IA et al. Endothelial stimulation by DDAVP in von Willebrand's disease and haemophilia. 1986 Haemostasis pmid:3084364
Slotman GJ et al. Interaction of prostaglandins, activated complement, and granulocytes in clinical sepsis and hypotension. 1986 Surgery pmid:3520916
Emms H and Lewis GP The roles of prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation in man and the rat. 1986 Br. J. Pharmacol. pmid:3082399
Shinonaga M et al. [Sequential measurements of TxB2 and 6-keto PGF1 alpha in cerebrospinal fluid and serum in patients with subarachnoid hemorrhage]. 1986 Neurol. Med. Chir. (Tokyo) pmid:2429203
Nagatsuka K et al. A new approach to antithrombotic therapy--evaluation of combined therapy of thromboxane synthetase inhibitor and very low dose of aspirin. 1985 Sep-Oct Stroke pmid:3931302
Codde JP et al. Changes in prostanoid synthesis in response to diet and hypertension in one-kidney, one clip rats. 1985 Nov-Dec Hypertension pmid:3908314
Lamy M et al. Biochemical pathways of acute lung injury. 1985 May-Jun Bull Eur Physiopathol Respir pmid:3873973
Jolly SR et al. Platelet depletion in experimental myocardial infarction. 1985 May-Jun Basic Res. Cardiol. pmid:4026785
Hillbom M et al. Effects of ethanol on platelet function. 1985 May-Jun Alcohol pmid:4026960
Uyama O et al. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease. 1985 Mar-Apr Stroke pmid:3883580
Fujimoto T et al. Cerebrovascular injuries induced by activation of platelets in vivo. 1985 Mar-Apr Stroke pmid:3975962
Mullane KM and McGiff JC Platelet depletion and infarct size in an occlusion-reperfusion model of myocardial ischemia in anesthetized dogs. 1985 Jul-Aug J. Cardiovasc. Pharmacol. pmid:2410715
Miura K et al. Effect of SA-446, an angiotensin-converting enzyme inhibitor, on renal function in anesthetized dogs: special reference to arachidonic acid metabolites. 1985 Jan-Feb J. Cardiovasc. Pharmacol. pmid:2580127
Olanoff LS et al. Protective effects of trans-13-APT, a thromboxane receptor antagonist, in endotoxemia. 1985 Jan-Feb J. Cardiovasc. Pharmacol. pmid:2580129
Hook BG et al. Experimental coronary artery thrombosis in the absence of thromboxane A2 synthesis: evidence for alternate pathways for coronary thrombosis. 1985 Jan-Feb J. Cardiovasc. Pharmacol. pmid:2580139
Fisher M and Zipser R Increased excretion of immunoreactive thromboxane B2 in cerebral ischemia. 1985 Jan-Feb Stroke pmid:3966251
Greer IA et al. Inhibition of thromboxane and prostacyclin production in whole blood by adrenoceptor antagonists. 1985 Prostaglandins Leukot Med pmid:2865745
Mikhailidis DP et al. The effect of non-specific beta-blockade on metabolic and haemostatic variables during hypoglycaemia. 1985 Diabetes Res. pmid:2866057
Mehta J et al. Increase in human platelet alpha 2-adrenergic receptor affinity for agonist in unstable angina. 1985 J. Lab. Clin. Med. pmid:2866219
Greer IA et al. A comparative study of the effects of adrenoceptor antagonists on platelet aggregation and thromboxane generation. 1985 Thromb. Haemost. pmid:2867620
Gragnoli G et al. Effects of somatostatin on the behaviour of thromboxane B2 and beta-thromboglobulin in type I diabetes. 1985 Acta Endocrinol. pmid:2408435
Yardumian DA et al. Platelet hyperaggregability occurring during prolonged continuous intravenous infusions of prostacyclin analogue ZK 36374. 1985 Br. J. Haematol. pmid:2408653
Patrassi GM et al. Contact phase of coagulation in diabetes mellitus after aspirin administration. 1985 Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. pmid:2410343
Papanicolaou N et al. Selective inhibition of renal thromboxane biosynthesis increased sodium excretion rate in normal and saline-loaded rats. 1985 Clin. Sci. pmid:3880524
Brown EM and Swartz SL Production of prostaglandins by dispersed cells and fragments from bovine parathyroid glands. 1985 Prostaglandins pmid:3883430
Boraschi D et al. Regulation of arachidonic acid metabolism in macrophages by immune and nonimmune interferons. 1985 J. Immunol. pmid:3923110
Walsh SW Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. 1985 Am. J. Obstet. Gynecol. pmid:3923838
Kiyomiya K and Oh-ishi S Involvement of arachidonic acid metabolites in acute inflammation: detection of 6-keto-PGF1 alpha, thromboxane B2 and PGD2 in rat pleurisy induced by phorbol myristate acetate. 1985 Jpn. J. Pharmacol. pmid:3936958
Stenmark KR et al. Alveolar inflammation and arachidonate metabolism in monocrotaline-induced pulmonary hypertension. 1985 Am. J. Physiol. pmid:3923843
Quilley J and McGiff JC Arachidonic acid metabolism and urinary excretion of prostaglandins and thromboxane in rats with experimental diabetes mellitus. 1985 J. Pharmacol. Exp. Ther. pmid:3925127
O'Keefe EH et al. Effects of a thromboxane synthetase inhibitor and a thromboxane antagonist on release and activity of thromboxane A2 and prostacyclin in vitro. 1985 Prostaglandins pmid:3925501
Mobley A and Tai HH Synergistic stimulation of thromboxane biosynthesis by calcium ionophore and phorbol ester or thrombin in human platelets. 1985 Biochem. Biophys. Res. Commun. pmid:3927908
Jakubowski JA et al. Cumulative antiplatelet effect of low-dose enteric coated aspirin. 1985 Br. J. Haematol. pmid:3927970
Mehta J et al. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides. 1985 J. Lab. Clin. Med. pmid:3928780
Sawada M et al. Enzyme-immunoassay of thromboxane B2 at the picogram level. 1985 Prostaglandins pmid:3929333
De Caterina R et al. Low-dose aspirin in patients recovering from myocardial infarction. Evidence for a selective inhibition of thromboxane-related platelet function. 1985 Eur. Heart J. pmid:3930246
Fukuda Y [Plasma prostaglandin and thromboxane levels in asthmatic children]. 1985 Arerugi pmid:2992423
Gorczynska E et al. [Effect of various stimulators on cyclooxygenase activity, platelet aggregation and TxB2 synthesis after using a platelet inhibitor (Aspro Clear) in vivo and in vitro]. 1985 Wiad. Lek. pmid:3933184
Honda M et al. Effects of purified hog pancreatic kallikrein on the kinin-prostaglandin system and renin-angiotensin-aldosterone system. 1985 Nephron pmid:2993934
Mehta P et al. Plasma concentrations of thromboxane and prostacyclin metabolites in patients with bone tumors. 1985 Am J Pediatr Hematol Oncol pmid:2994511
Benigni A et al. Inhibition of human platelet aggregation by parathyroid hormone. Is cyclic AMP implicated? 1985 Am. J. Nephrol. pmid:2996352
Leslie JB and Watkins WD Eicosanoids in the central nervous system. 1985 J. Neurosurg. pmid:2997413
Darius H et al. Beneficial effects of a new potent and specific thromboxane receptor antagonist (SQ-29,548) in vitro and in vivo. 1985 J. Pharmacol. Exp. Ther. pmid:2997428
Mitchell JA et al. Effects of high frequency oscillatory ventilation compared to conventional ventilation upon pulmonary vascular prostanoid production in neonatal piglets. 1985 Prostaglandins Leukot Med pmid:3883366
Wang JP et al. Antiplatelet effect of hsien-ho-t'sao (Agrimonia pilosa). 1985 Am. J. Chin. Med. pmid:3927704
Wenger H et al. Pulmonary dysfunction secondary to soft-tissue endotoxin. 1985 Arch Surg pmid:3883949
Hashimoto Y et al. Time-dependent inhibition of the cyclooxygenase pathway by 12-hydroperoxy-5,8,10,14-eicosatetraenoic acid. 1985 Biochem. Biophys. Res. Commun. pmid:3927909
Meyrick B et al. Endothelial prostacyclin production is a late event in granulocyte migration into bovine pulmonary artery intimal explants. 1985 Blood pmid:3904871
Túri S et al. [Changes in serum prostaglandin metabolites in Schönlein-Henoch purpura]. 1985 Orv Hetil pmid:3897944
Farias LR et al. Effect of prostaglandin blockers on ascites fluid in pancreatitis. 1985 Surgery pmid:3898455
Kubo K and Kobayashi T Effects of OKY-046, a selective thromboxane synthetase inhibitor, on endotoxin-induced lung injury in unanesthetized sheep. 1985 Am. Rev. Respir. Dis. pmid:3898941
Barst RJ and Stalcup SA Endothelial function in clinical pulmonary hypertension. 1985 Chest pmid:3899537
Pedersen AK and FitzGerald GA Cyclooxygenase inhibition, platelet function, and metabolite formation during chronic sulfinpyrazone dosing. 1985 Clin. Pharmacol. Ther. pmid:3917387
Pediconi M et al. Effects of acute and chronic ethanol administration on thromboxane and prostacyclin levels and release in rat brain cortex. 1985 Prostaglandins pmid:3901122
Neri Serneri GG et al. Abnormal cardiocoronary thromboxane A2 production in patients with unstable angina. 1985 Am. Heart J. pmid:3984828
Vesterqvist O et al. In vivo production of thromboxane in acute human myocardial infarction: a preliminary study. 1985 Thromb. Res. pmid:3992528
Wirthumer-Hoche C and Sinzinger H [Protein binding of thromboxane--one of the sources of error in thromboxane determination]. 1985 Wien. Klin. Wochenschr. pmid:3993037
Barst RJ et al. Relation of arachidonate metabolites to abnormal control of the pulmonary circulation in a child. 1985 Am. Rev. Respir. Dis. pmid:3917630
Halenda SP et al. Phorbol esters and oleoyl acetoyl glycerol enhance release of arachidonic acid in platelets stimulated by Ca2+ ionophore A23187. 1985 J. Biol. Chem. pmid:3930496
Zahavi J and Zahavi M Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease. 1985 Thromb. Haemost. pmid:3158092
Roy L et al. Lack of efficacy of nafazatrom, a novel anti-thrombotic compound, in patients with coronary artery disease. 1985 Am. Heart J. pmid:3158183
Pedrinelli R et al. The influence of selective and nonselective prostaglandin inhibition on renin. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:3159197
Reines HD et al. Dazoxiben in human sepsis and adult respiratory distress syndrome. 1985 Clin. Pharmacol. Ther. pmid:3979000
Greco NJ et al. Action of platelet-activating factor on type 1 diabetic human platelets. 1985 J. Lab. Clin. Med. pmid:3981054
Patterson GA et al. Effects of imidazole and indomethacin on fluid balance in isolated sheep lungs. 1985 J. Appl. Physiol. pmid:3884582
Prosdocimi M et al. Coronary and systemic 6-ketoprostaglandin F1 alpha and thromboxane B2 during myocardial ischemia in dog. 1985 Am. J. Physiol. pmid:3838623
Krieger BP et al. Mechanisms of interaction between oxygen and granulocytes in hyperoxic lung injury. 1985 J. Appl. Physiol. pmid:3838744
Valentovic MA and Lubawy WC Elevated glucose in vivo and in vitro adversely alters prostaglandin generation in rat aortas and platelets. 1985 Prostaglandins Leukot Med pmid:3903777
Bergqvist D et al. The effect of inhibition of thromboxane synthesis in experimental thrombosis and hemostasis. 1985 Thromb. Res. pmid:3838828
Stuart MJ et al. Prostanoids in hemolytic uremic syndrome. 1985 J. Pediatr. pmid:3839015
Nigam S et al. The concentrations of 6-keto-PGF1 alpha and TXB2 in plasma samples from patients with benign and malignant tumours of the breast. 1985 Prostaglandins pmid:3839084
Petroni A et al. Differential effects of various vasoactive drugs on basal and stimulated levels of TXB2 and 6-keto-PGF1 alpha in rat brain. 1985 Prostaglandins pmid:3839085
Zipser RD Effects of selective inhibition of thromboxane synthesis on renal function in humans. 1985 Am. J. Physiol. pmid:3839111
Mendieta CF et al. Biosynthesis of prostaglandins in gingiva of patients with chronic periodontitis. 1985 J. Periodontol. pmid:3919173
Fink MP et al. Low-dose dopamine preserves renal blood flow in endotoxin shocked dogs treated with ibuprofen. 1985 J. Surg. Res. pmid:3839278
Haurand M and Ullrich V Isolation and characterization of thromboxane synthase from human platelets as a cytochrome P-450 enzyme. 1985 J. Biol. Chem. pmid:2999104
Chang J et al. Modulation by hydroxyeicosatetraenoic acids (HETEs) of arachidonic acid metabolism in mouse resident peritoneal macrophages. 1985 Eur. J. Pharmacol. pmid:3920057
Hillbom M et al. Platelet thromboxane formation and bleeding time is influenced by ethanol withdrawal but not by cigarette smoking. 1985 Thromb. Haemost. pmid:4049313
Aviram M et al. Plasma lipoproteins affect platelet malondialdehyde and thromboxane B2 production. 1985 Biochem Med pmid:4052061
Simmet T et al. Modulation of eicosanoid release from anaphylactic guinea-pig heart with 5-benzoyl-a-methyl-2-thiophene acetic acid (tiaprofenic acid). 1985 Arch Int Pharmacodyn Ther pmid:3841634
Rinaldo JE and Dauber JH Effect of methylprednisolone and of ibuprofen, a nonsteroidal antiinflammatory agent, on bronchoalveolar inflammation following endotoxemia. 1985 Circ. Shock pmid:4053294
Shingu T [Prostaglandin metabolism in ischemic brain edema]. 1985 Nihon Geka Hokan pmid:3841635
Leffler CW and Busija DW Prostanoids in cortical subarachnoid cerebrospinal fluid and pial arterial diameter in newborn pigs. 1985 Circ. Res. pmid:4053302
Shohami E and Gross J An ex vivo method for evaluating prostaglandin synthetase activity in cortical slices of mouse brain. 1985 J. Neurochem. pmid:3923156
Tobian L et al. Prostaglandin alterations in barely hypertensive Dahl S rats. 1985 Trans. Assoc. Am. Physicians pmid:3842205
Ment LR et al. Beagle puppy model of perinatal cerebral infarction. Acute changes in regional cerebral prostaglandins during hemorrhagic hypotension. 1985 J. Neurosurg. pmid:4056903
Numano F et al. Coronary spasm, prostaglandin and HLA factors. 1985 Jpn. Circ. J. pmid:3855470
Katoh K et al. [Serial changes in plasma thromboxane and complement in ARDS--effect of the thromboxane synthetase inhibitor]. 1985 Masui pmid:4057547
Purkerson ML et al. Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation. 1985 Proc. Natl. Acad. Sci. U.S.A. pmid:3855542
Dahl ML and Uotila P Sodium salicylate does not prevent the inhibitory effect of indomethacin on thromboxane formation in human blood ex vivo. 1985 Prostaglandins Leukot Med pmid:3856282
Kääpä P Immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in neonatal hyperbilirubinemia. 1985 Prostaglandins Leukot Med pmid:3856285
Gay SW and Kosher RA Prostaglandin synthesis during the course of limb cartilage differentiation in vitro. 1985 J Embryol Exp Morphol pmid:3867724
Zijlstra FJ and Vincent JE Leukotriene D4 and phospholipase A2 release thromboxane A2 of different origin in the guinea pig lung parenchymal strip. 1985 Prostaglandins Leukot Med pmid:3857642
Sterk PJ et al. Limited maximal airway narrowing in nonasthmatic subjects. Role of neural control and prostaglandin release. 1985 Am. Rev. Respir. Dis. pmid:2864892